focused ultrasound ablation
Recently Published Documents


TOTAL DOCUMENTS

345
(FIVE YEARS 83)

H-INDEX

35
(FIVE YEARS 3)

2021 ◽  
Vol 35 (S2) ◽  
pp. S-24-S-32
Author(s):  
Lauren R. Abrams ◽  
Michael O. Koch ◽  
Clinton D. Bahler

2021 ◽  
Vol 38 (2) ◽  
pp. 56-64
Author(s):  
Simon H. Tsang ◽  
Ka Wing Ma ◽  
Wong Hoi She ◽  
Ferdinand Chu ◽  
Vince Lau ◽  
...  

2021 ◽  
Vol 28 ◽  
Author(s):  
Zeng Zeng ◽  
Ji-Bin Liu ◽  
Cheng-Zhong Peng

: This review describes how phase-changeable nanoparticles enable highly efficient high-intensity focused ultrasound ablation (HIFU). HIFU is effective in the clinical treatment of solid malignant tumors. However, it has intrinsic disadvantages for treating some deep lesions, such as damage to surrounding normal tissues. When phase-changeable nanoparticles are used in HIFU treatment, they could serve as good synergistic agents because they are transported in the blood and permeated and accumulated effectively in tissues. HIFU’s thermal effects can trigger nanoparticles to undergo a special phase transition, thus enhancing HIFU ablation efficiency. Nanoparticles can also carry anticancer agents and release them in the targeted area to achieve chemo-synergistic therapy response. Although the formation of nanoparticles is complicated and HIFU applications are still in an early stage, the potential for their use in synergy with HIFU treatment shows promising results.


Sign in / Sign up

Export Citation Format

Share Document